Latest Funding News

Orion Minerals is on the cusp of finalising a significant financing and offtake agreement with Glencore, potentially unlocking up to US$250 million for its Prieska Copper Zinc Mine.

88 Energy Limited has expanded its North Slope footprint with 14 new leases near the Prudhoe Bay oilfield, targeting high-quality Ivishak reservoirs and underexplored areas east of the Trans Alaska Pipeline. The company plans seismic reprocessing and a multi-zone exploration well in 2026.

Strickland Metals reports strong diamond drilling results at its Shanac Deposit in Serbia, revealing extensive gold and base metals mineralisation and confirming potential for resource growth beyond 5.3Moz AuEq.

Adelong Gold’s initial diamond drilling at the Lauriston Gold-Antimony Project has revealed visible gold, validating historic high-grade results and setting the stage for an expanded exploration campaign.

Power Minerals and Navigate Energy have taken a major step forward by finalising the incorporation of their Rincon Lithium Project Joint Venture entity in Argentina, paving the way for a US$4 million investment to accelerate project development.

Raiden Resources has acquired an 85% commercial interest in the Crixás Gold Tailings Project in Brazil, aiming to unlock near-term, low-capital gold production through tailings reprocessing. The project features existing infrastructure and a third-party processing plant, with a feasibility study underway for a larger gravity processing facility.

Cash Converters has completed a $25 million equity raise to fund the acquisition of 29 Australian franchise stores, with EZCORP increasing its voting power to nearly 44%.

Australian Agricultural Company Limited (AACo) reported a record first-half operating profit of $39.8 million, boosted by higher beef and cattle prices and volumes, alongside strategic investments in feedlot expansion and carbon projects.

Turners Automotive Group has delivered a record first-half profit for FY26, driven by strong growth in its Finance and Insurance divisions despite ongoing supply constraints in the used vehicle market. The company also raised its interim dividend, signalling confidence in its diversified business model and capital management strategy.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.